HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Cost-Cutting Successes Inspire New Moves In Productivity

This article was originally published in The Rose Sheet

Executive Summary

P&G has “identified and will appoint” a senior group president to new position of global officer, productivity and organization transformation, firm announces during first quarter conference call Oct. 25. Cost-cutting measures contributed to higher EPS than initially estimated.

You may also be interested in...



P&G Shareholders Push For More Power Over Board Membership

Firm’s shareholders will be able to make board changes via simple majority votes (versus super-majority votes) if P&G adopts a proposal backed by a 59.3% of shareholders at an Oct. 9 meeting. The change could allow a shakeup of P&G leadership, with rumors circulating that activist investor William Ackman wants CEO Bob McDonald out.

P&G Targets $10 Billion In Cost Savings In Four Years

P&G will $10 billion in costs by the end of fiscal 2016, firm says at Analyst Group of New York Conference Feb. 23. Firm aims to derive $3 billion of that from reduced overhead, with plans to cut 5,700 jobs by the end of next fiscal year.

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018341

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel